What we do
We bring scientists and clinicians together to advance our knowledge of pregnancy and childbirth. Our aim is to enable research to be translated into new treatments to prevent preterm birth.
Borne's approach to research
We combine the clinical and the scientific
We support the vital collaboration between the point of care and the laboratory. This means that our studies serve the dual purpose of finding crucial answers and improving care for mothers and babies.
We pump-prime promising new research
Through an independent Scientific Advisory Board, we select the most promising early-stage research projects in the field, for which our funding will be the ‘kickstarter’ they need to progress on a larger scale.
By supporting research at this stage, we enable scientists to successfully apply for further funding from research councils and other grant-making bodies for further and larger studies, effectively leveraging the contribution of Borne’s supporters several times over the initial investment.
We foster collaboration to accelerate progress
We believe that the answers we are searching for are likely to lie at the seams between different areas of scientific focus, and we know that the problem of premature birth is too big to solve on our own.
We foster collaboration between scientific experts and clinicians, as well as partnering with other research funders to maximise our impact.
Borne's research strategy
Our research focus
The research that Borne funds is focused on pregnancy and labour, and arising complications that may lead to preterm birth.
What we fund
Borne offers funding to take the most promising ideas in the field forward, encourage collaboration and career development.
FUNDING FOR RESEARCHERS
How you can apply for funding from Borne
The research we fund
Our research ambition
In early 2020, Borne convened a series of meetings with a group of preterm birth experts from around the world to advise how Borne might most meaningfully facilitate a collaboration that can enable a quantum leap in progress.
This scientific collaborative identified the need for a unique bio resource that enabled the systematic study if the biological interactions across different cells and tissues to advance our understanding of normal and dysfunctional labour and to identify new interventions to delay or prevent preterm labour.